Cyclin D1 protein overexpression was assessed by 21 studies in 1473 melanomas (range: 7–245); CCND1 gene amplification was also analyzed by 22 studies in 2096 melanomas (range: 6–514). This evidence concerns the gene CCND1 and melanoma.